🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 hora
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
14/12/2022 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/10/2002 51,15 51,99 50,70 51,76 +1,48% 2,54% 5.663.497
29/10/2002 51,19 52,30 50,11 51,00 -1,44% 4,27% 7.656.688
28/10/2002 51,91 52,71 51,36 51,75 +2,49% 2,61% 12.329.930
25/10/2002 48,18 50,55 47,82 50,49 +4,79% 5,66% 6.544.236
24/10/2002 49,11 49,57 47,76 48,18 -1,69% 3,69% 6.012.690
23/10/2002 47,69 49,06 47,43 49,01 +1,40% 3,40% 7.088.148
22/10/2002 48,09 48,57 47,49 48,33 -0,98% 2,24% 6.047.798
21/10/2002 47,09 49,11 47,00 48,81 +0,24% 4,48% 8.224.494
18/10/2002 48,43 48,85 46,85 48,69 +0,55% 4,12% 11.185.828
17/10/2002 48,86 48,89 47,83 48,43 +1,70% 2,17% 6.491.312
16/10/2002 48,62 49,24 47,15 47,61 -1,93% 4,30% 7.044.761
15/10/2002 48,28 48,68 47,81 48,55 +2,58% 1,80% 9.736.339
14/10/2002 45,14 47,99 45,14 47,33 +4,86% 6,30% 9.880.125
11/10/2002 43,90 45,52 43,64 45,13 +2,80% 4,30% 5.636.982
10/10/2002 43,54 44,13 42,40 43,90 +0,83% 3,99% 9.122.840
09/10/2002 42,46 44,79 41,36 43,54 -0,80% 8,07% 12.833.808
08/10/2002 42,94 44,66 42,59 43,89 +4,24% 4,82% 7.907.789
07/10/2002 42,33 44,04 41,94 42,11 -0,29% 4,96% 6.666.538
04/10/2002 43,71 43,89 41,77 42,23 -4,39% 4,87% 8.416.698
03/10/2002 44,70 45,94 43,67 44,17 -1,41% 5,06% 6.522.123
02/10/2002 44,80 45,68 44,42 44,80 +1,23% 2,81% 6.852.348
01/10/2002 44,18 44,37 43,23 44,26 +1,47% 2,57% 9.034.284
30/09/2002 44,14 44,32 43,05 43,62 -1,19% 2,88% 7.777.942
27/09/2002 45,71 46,28 43,94 44,14 -5,11% 5,11% 7.951.176
26/09/2002 45,52 46,52 45,31 46,52 +2,20% 2,64% 6.995.190
25/09/2002 44,18 45,80 44,09 45,52 +3,92% 3,87% 6.686.135
24/09/2002 42,61 44,11 42,40 43,80 +1,44% 4,01% 6.743.356
23/09/2002 42,99 43,65 42,76 43,18 -1,07% 2,06% 5.589.718
20/09/2002 43,11 43,98 43,11 43,65 +1,22% 2,01% 10.351.306
19/09/2002 43,96 44,75 43,01 43,12 -3,97% 3,97% 5.852.137